Order results by:
Issue | Title | |
Vol 13, No 4 (2017) | USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA | Abstract similar documents |
O. M. Drapkina, A. S. Lishuta | ||
"... perindopril,rosuvastatin and fixed-dose combination of perindopril and indapamide, in ambulatory patients ..." | ||
Vol 13, No 2 (2017) | COMBINATION THERAPY OF HIGH-RISK PATIENTS IN REAL CLINICAL PRACTICE. RESULTS OF SYNERGY STUDY. PART 1. ANTIHYPERTENSIVE BRANCH | Abstract similar documents |
O. M. Drapkina | ||
"... , including perindopril (monotherapy or fixed combination with indapamide or amlodipine) and rosuvastatin ..." | ||
Vol 13, No 3 (2017) | TREATMENT OF ARTERIAL HYPERTENSION AND DYSLIPIDEMIA IN REAL CLINICAL PRACTICE. THE SYNERGY STUDY. Part 2 | Abstract similar documents |
O. M. Drapkina, A. S. Luishuta | ||
"... of perindopril 8 mg+amlodipine 10 mg+rosuvastatin 5 mg (41.4 mm Hg), and this in diastolic BP – in the group ..." | ||
Vol 15, No 6 (2019) | Russian Trial ALGORITHM: Implementation of Combined Antihypertensive and Hypolipidemic Treatment for Clinical Efficacy Achievement in Routine Clinical Practice | Abstract similar documents |
D. A. Napalkov | ||
"... /perindopril, amlodipine/indapamide/perindopril and rosuvastatin in patients with hypertension and high/very ..." | ||
Vol 10, No 5 (2014) | STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE | Abstract similar documents |
L. N. Malay | ||
"... on rosuvastatin. Data of recent metaanalysis regarding statins efficacy in primary and secondary prevention ..." | ||
Vol 8, No 5 (2012) | LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS | Abstract similar documents |
A. N. Meshkov | ||
"... Assessment of lipid-lowering effect of rosuvastatin is presented, as well as the main results ..." | ||
Vol 14, No 4 (2018) | Statin Therapy and Cognitive Impairment: Benefit or Harm? | Abstract similar documents |
O. D. Ostroumova, E. V. Chikh, E. V. Rebrova, A. Yu. Ryazanova | ||
"... and reducing the risk of potential cognitive impairment during statin therapy. Rosuvastatin may be safer ..." | ||
Vol 6, No 4 (2010) | COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AFTER THE STROKE | Abstract similar documents |
O. A. Ageenkova, V. A. Milyagin, N. Yu. Hozyainova | ||
"... Aim. To evaluate influence of the combined therapy with ACE inhibitor (perindopril), diuretic ..." | ||
Vol 18, No 2 (2022) | The problem of choice: original drug or generic? Emphasis on rosuvastatin | Abstract similar documents |
O. A. Polyakova, O. D. Ostroumova | ||
"... is described by the example of such a hypolipidemic agent as rosuvastatin. According to numerous studies ..." | ||
Vol 7, No 4 (2011) | PERINDOPRIL: THE POSSIBILITY OF ANTIHYPERTENSIVE AND RENOPROTECTIVE THERAPY | Abstract similar documents |
O. V. Dralova, M. L. Maksimov | ||
"... problems in modern cardiology and nephrology. Perindopril therapy reduces cardiovascular risk in patients ..." | ||
Vol 9, No 5 (2013) | THE PROBLEM OF MEDICINES INTERCHANGEABILITY. FOCUS ON PERINDOPRIL | Abstract similar documents |
A. I. Malyhina, M. V. Zhuravleva, A. K. Starodubtsev, M. L. Maksimov, O. A. Rogacheva | ||
"... Aim. To evaluate the therapeutic equivalence between generic perindopril (Parnavel, LLC Ozone ..." | ||
Vol 18, No 4 (2022) | Therapeutic Options for the Single Pill Combination of Lisinopril, Amlodipine and Rosuvastatin: a Systematic Review | Abstract similar documents |
S. R. Gilyarevsky, M. V. Golshmid, N. G. Bendeliani | ||
"... and rosuvastatin on blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C) in hypertensive patients ..." | ||
Vol 5, No 2 (2009) | OBSERVATIONAL TRAILS IN LIPIDOLOGY | Abstract similar documents |
S. A. Shalnova | ||
Vol 7, No 1 (2011) | ATHEROSCLEROSIS: HOW TO START UP A "COUNT DOWN" CLOCK? WE DON'T KNOW, WE CAN NOT OR WE DO NOT WANT? | Abstract similar documents |
L. N. Malay | ||
"... Clinical cases of long-term use of rosuvastatin are presented with an estimation of its effect ..." | ||
Vol 7, No 4 (2011) | USE OF ROSUVASTATIN AS A GEROPROTECTOR IN PEOPLE ENGAGED IN NATURAL GAS PRODUCING | Abstract similar documents |
A. T. Abdrashitova, T. N. Panova, I. A. Belolapenko, M. V. Frenkel | ||
"... for pathogenetic way for aging process deceleration. Aim. To study the geroprotective properties of rosuvastatin ..." | ||
Vol 8, No 3 (2012) | STATINS AND MYOPATHY: MOLECULAR MECHANISMS | Abstract similar documents |
O. M. Drapkina, E. M. Chernova, O. N. Korneeva | ||
Vol 14, No 5 (2018) | Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome | Abstract PDF (Eng) similar documents |
Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal | ||
"... -term safety and efficacy of full dose rosuvastatin and atorvastatin in patients with acute coronary ..." | ||
Vol 8, No 4 (2012) | UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES | Abstract similar documents |
N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina | ||
"... the benefits of rosuvastatin in the prevention and treatment of cardiovascular diseases are presented. ..." | ||
Vol 18, No 5 (2022) | The Problem of Drug Interactions Between Rosuvastatin and Ticagrelor in the Aspect of the Risk of Rhabdomyolysis: Discussion of the Problem and Description of the Clinical Case | Abstract similar documents |
O. V. Gaisenok, Yu. M. Chichkov, M. V. Leonova | ||
"... that, rosuvastatin 40 mg per day and ticagrelor 90mg 2 times a day were added to her therapy. During the current ..." | ||
Vol 15, No 2 (2019) | Modern Recommendations and Real Clinical Practice: the Results of the SILA Study | Abstract similar documents |
O. A. Kislyak, I. I. Chukaeva, V. A. Vygodin | ||
"... Aim. To assess efficacy and safety of single-pill combination (SPC) amlodipine/perindopril ..." | ||
Vol 10, No 5 (2014) | EFFICACY OF ROSUVASTATIN IN DYSLIPIDEMIA CORRECTION IN PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION | Abstract similar documents |
R. D. Kurbanov, N. U. Zakirov, Y. G. Kevorkova, N. B. Sayfiddinova | ||
"... Aim. To study the efficacy of rosuvastatin in dyslipidemia correction in patients after Q-wave ..." | ||
Vol 7, No 3 (2011) | COMPARATIVE EVALUATION OF THE ANTIHYPERTENSIVE EFFECT OF PERINDOPRIL AND LOSARTAN POTASSIUM IN PATIENTS WITH ARTERIAL HYPERTENSION AND STENOTIC CORONARY ATHEROSCLEROSIS BEFORE REVASCULARIZATION: AN OPEN RANDOMIZED COMPARATIVE STUDY | Abstract similar documents |
O. A. Osipova, N. N. Kurbakov, A. G. Ovsyannikov, M. A. Vlasenko | ||
"... Aim. To compare effects of perindopril and losartan potassium on the parameters of the ambulatory ..." | ||
Vol 7, No 3 (2011) | STROKE PREVENTION IN INTERNIST PRACTICE | Abstract similar documents |
D. A. Napalkov, A. V. Zhilenko | ||
"... adjusting individual treatment depending on clinical conditions. The composition of perindopril ..." | ||
Vol 16, No 5 (2020) | Hypertension and Hypercholesterolemia: is it Time for Anti-«Lipitensive» Therapy? | Abstract similar documents |
Z. D. Kobalava, E. V. Kokhan | ||
"... combination of indapamide, perindopril and rosuvastatin, the requirements for fixed drug combinations ..." | ||
Vol 14, No 3 (2018) | THE POSSIBILITIES OF USING A NEW FIXED-DOSE COMBINATION OF ROSUVASTATIN AND ACETYLSALICYLIC ACID: FOCUS GROUPS OF PATIENTS | Abstract similar documents |
O. D. Ostroumova, A. I. Kochetkov, N. Yu. Voevodina, S. S. Sharonova | ||
Vol 6, No 2 (2010) | COMPARISON OF ENALAPRIL AND PERINDOPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND LEFT VENTRICLE SYSTOLIC DYSFUNCTION | Abstract similar documents |
Yu. I. Grinshtein, O. L. Barbarash, D. A. Yakhontov, A. E. Popelysheva, V. V. Shabalin, N. B. Osetrova | ||
"... Aim. To compare efficacy of enalapril and perindopril in patients with arterial hypertension (HT ..." | ||
Vol 12, No 2 (2016) | LIPID-LOWERING THERAPY IN OUTPATIENT PRACTICE (ACCORDING TO THE ARGO-2 STUDY) | Abstract similar documents |
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, A. N. Tkacheva, A. S. Lishuta | ||
"... Aim. To study the features of lipid-lowering therapy with rosuvastatin in high and very high ..." | ||
Vol 3, No 5 (2007) | WHETHER THE STUDY ON EFFICACY OF ROSUVASTATIN IN ELDERLY PATIENTS WITH HEART FAILURE AND SYSTOLIC DYSFUNCTION OF LEFT VENTRICLE HAD BEEN COMPLETED WITH “CROWNING”? | Abstract similar documents |
S. R. Gilyarevsky | ||
"... Whether the study on efficacy of rosuvastatin in elderly patients with heart failure and systolic ..." | ||
Vol 7, No 1 (2011) | SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW | Abstract similar documents |
S. R. Gilyarevskiy, V. A. Orlov, M. V. Golshmid, G. Yu. Zakharova, I. I. Sinitsina | ||
Vol 12, No 6 (2016) | THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 | Abstract PDF (Eng) PDF (Eng) similar documents |
S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov | ||
"... .5%, whereas prescription of atorvastatin and rosuvastatin increased from 31.4% to 64.5% and from 3.6% to 9 ..." | ||
Vol 16, No 2 (2020) | Drug Correction of Vascular Remodeling in Patients with Hypertension: Results of 52-Week Prospective Study ARTERIA-AG | Abstract similar documents |
O. V. Fedorishina, K. V. Protasov, A. M. Torunova | ||
"... antihypertensive therapy and additionally rosuvastatin (20 mg/day). The follow-up period was 52 weeks. The effect ..." | ||
Vol 14, No 6 (2018) | Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study) | Abstract PDF (Eng) similar documents |
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, N. A. Dmitrieva, S. V. Blagodatskikh, O. V. Lerman, T. A. Gomova, S. I. Drozdetsky, V. V. Skibitskiy, E. A. Kudryashov, N. F. Puchinyan | ||
"... or rosuvastatin was recommended for all patients. To assess adherence the following surveys were used: medical ..." | ||
Vol 16, No 5 (2020) | Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) | Abstract similar documents |
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko | ||
"... and rosuvastatin in an individually prescribed dose. After 1 month (B1), if the target level of lowdensity ..." | ||
Vol 2, No 2 (2006) | THE INFLUENCE OF LONG-TERM THERAPY WITH PERINDOPRIL ON THE HEART INOTROPIC FUNCTION IN PATIENTS WITH CHRONIC POSTINFARCTION ANEURISM | Abstract similar documents |
I. G. Fomina, N. A. Galanina, Z. O. Georgadze, N. E. Gaidamakina | ||
"... Aim. To study the influence of long-term therapy with perindopril on the heart inotropic function ..." | ||
Vol 9, No 6 (2013) | COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY | Abstract similar documents |
I. V. Zhirov, G. K. Sarbalinova, S. N. Tereschenko | ||
"... Aim. To study the clinical and hemodynamic efficacy of monotherapy with ACE inhibitor perindopril ..." | ||
Vol 17, No 4 (2021) | Epidemiological Observational Study on the Assessment of the Comorbidity and the Efficacy of the Treatment of Hypertensive Patients with Single Pill Combination of Lysinopril, Amlodipine and Rosuvastatin "PHENOTYPE-AG" | Abstract similar documents |
M. P. Savenkov, S. N. Ivanov, M. V. Borschevskaya, I. N. Okuneva, S. V. Ivanova, A. M. Savenkova, R. V. Dushkin | ||
"... , amlodipine and rosuvastatin (SPC LAR) in hypertensive patients. Material and methods. Observational ..." | ||
Vol 3, No 4 (2007) | RESULTS AND COMMENTS ON ADVANCE STUDY | Abstract similar documents |
S. R. Gilyarevsky | ||
"... Влияние сочетанного применения фиксированной комбинации периндоприла и индапамида на частоту ..." | ||
Vol 4, No 2 (2008) | ACE INHIBITORS ARE RATIONAL PHARMACOTHERAPY OF ENDOTHELIAL DYSFUNCTION | Abstract similar documents |
M. P. Metrova, A. B. Salmina, A. I. Inzhutova, O. S. Bahmeteva | ||
"... Aim. To study effects of ACE inhibitor perindopril on markers of endothelial dysfunction ..." | ||
Vol 19, No 2 (2023) | Outpatient Practice of Lipid-Lowering Therapy Prescription (According to the ARGO-3 Study) | Abstract similar documents |
M. V. Ezhov, N. M. Akhmedzhanov, T. E. Kolmakova, A. V. Tyurina, A. I. Martynov | ||
"... .2% of cases, free combination of rosuvastatin with ezetimibe – in 17.2%, single pill combination ..." | ||
Vol 14, No 5 (2018) | Excessive Hypocoagulation in Therapy with Warfarin within Polypharmacy: Using online database Multi-Drug Interaction Checker and Graphic “Time-Effect-Drug Administration” to Eliminate Adverse Drug Event (Case Report) | Abstract similar documents |
G. S. Krasnov, I. V. Kazancev | ||
"... +rosuvastatin, warfarin+amiodarone. It was found that the patient had not taken rosuvastatin before ..." | ||
Vol 3, No 1 (2007) | THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION | Abstract similar documents |
D. B. Nebieridze, A. S. Safaryan | ||
"... of ACE inhibitors (ramipril, perindopril), which are associated with vasoprotection. ..." | ||
Vol 8, No 5 (2012) | ASSESSMENT OF THE CHANGES IN BLOOD PRESSURE CIRCADIAN PROFILE AND VARIABILITY IN PATIENTS WITH CHRONIC HEART FAILURE AND ARTERIAL HYPERTENSION DURING COMBINED THERAPY INCLUDING IVABRADINE | Abstract similar documents |
M. V. Surovtseva, N. A. Koziolova, A. I. Chernyavina | ||
"... on received drugs: perindopril and ivabradine - group 1; perindopril, bisoprolol and ivabradine - group 2 ..." | ||
Vol 6, No 4 (2010) | ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM? | Abstract similar documents |
D. V. Nebieridze, A. S. Safarian | ||
"... . However this property can not be extended to all ACE inhibitors. Only ramipril and perindopril have ..." | ||
Vol 6, No 6 (2010) | COMPARATIVE EFFICACY OF THE STATINS IN PREVENTING AND TREATING OF THE CORONARY HEART DISEASE | Abstract similar documents |
S. V. Shalaev, Z. M. Safiullina, L. V. Kremneva, O. V. Abaturova | ||
"... to therapy with atorvastatin and rosuvastatin was demonstrated in recent studies. The advantage of aggressive ..." | ||
Vol 18, No 3 (2022) | Lipid profile of patients with arterial hypertension who underwent COVID-19: possibilities of drug therapy/ LEADER | Abstract similar documents |
I. A. Zolotovskaya, V. P. Kuzmin, O. A. Rubanenko, P. R. Shatskaya, A. S. Salasyuk | ||
"... groups: group 1 (n=64) received a single pill combination of lisinopril + amlodipine + rosuvastatin; 2 ..." | ||
Vol 15, No 2 (2019) | Pharmacoepidemiological Research of the Efficacy of Fixed Dose Combinations in the Treatment of Patients with Arterial Hypertension in Ambulatory Practice | Abstract similar documents |
E. V. Yakukhnaya, E. V. Solyanik, V. V. Khitrina, Yu. V. Kuznetsova | ||
"... dose combinations in Vladivostok polyclinics was performed. Two-component (perindopril + amlodipine ..." | ||
Vol 5, No 5 (2009) | THE COMPARATIVE COST-EFFICACY ANALYSIS OF VARIOUS ANTIHYPERTENSIVE THERAPIES | Abstract similar documents |
S. V. Malchikova, E. I. Tarlovskaya | ||
"... indapamide retard plus perindopril; group B - indapamide retard plus amlodipine; group C - amlodipine plus ..." | ||
Vol 1, No 1 (2005) | ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES | Abstract similar documents |
Y. A. Karpov | ||
"... in patients without left ventricle dysfunction are demonstrated in studies EUROPA with perindopril 8 mg ..." | ||
Vol 14, No 6 (2018) | Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation | Abstract PDF (Eng) similar documents |
A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee | ||
"... are the cheapest among generics – about 17 rubles. The most expensive treatment with generics of rosuvastatin ..." | ||
Vol 21, No 2 (2025) | A randomized controlled trial of statin therapy effect on androgen status and erectile function in men with high and very high cardiovascular risk (TRISTAN): rationale and study protocol | Abstract similar documents |
K. P. Raevskii, O. Yu. Nesterova, A. A. Strigunov, M. E. Chaliy, A. V. Kadrev, A. G. Plisyuk, A. A. Kamalov, Ya. A. Orlova | ||
"... pitavastatin at a starting dose of 1 mg/day. Group 2 (n=75) will receive rosuvastatin 20 mg/day. After 3 months ..." | ||
Vol 4, No 1 (2008) | VASCULAR REMODELING AND HEART RATE VARIABILITY IN DIFFERENT ANTIHYPERTENSIVE THERAPIES | Abstract similar documents |
E. D. Golovanova | ||
"... and perindopril (Noliprel Forte, 1 tab/d: perindopril 4 mg and indapamide 1,25 mg) on pulse wave velocity (PWV ..." | ||
Vol 7, No 6 (2011) | COMPARATIVE EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH MODERATE ARTERIAL HYPERTENSION ACCOMPANIED BY TYPE 2 DIABETES | Abstract similar documents |
E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk | ||
"... in groups A, B or C. Patients of group A (n=25) received a fixed combination of the original perindopril ..." | ||
Vol 20, No 4 (2024) | BRAНH syndrome: clinical case | Abstract similar documents |
K. G. Pereverzeva, O. A. Fomina, Yu. S. Batishcheva, L. V. Filippov, S. S. Yakushin | ||
"... and permanent atrial fibrillation (AF). The patient took perindopril 10 mg, indapamide 2.5 mg, amlodipine 10 mg ..." | ||
Vol 16, No 3 (2020) | Dynamics of Vascular Stiffness and Endothelial Function in Combination Therapy of Heart Failure with Preserved Ejection Fraction | Abstract similar documents |
Z. M. Akhilgova, I. I. Almazova, N. K. Gabitova, E. A. Kotaeva, A. G. Avtandilov | ||
"... Aim. To assess the effect of combination therapy (perindopril, indapamide, amlodipine) on vascular ..." | ||
Vol 17, No 3 (2021) | Optimal Medical Therapy for Chronic Coronary Syndrome: Realities and Prospects | Abstract similar documents |
P. A. Lebedev, I. K. Petrukhina, A. A. Garanin, E. V. Paranina | ||
"... of three components (lisinopril, amlodipine and rosuvastatin), each of which has pleiotropic effects ..." | ||
Vol 11, No 3 (2015) | ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I | Abstract similar documents |
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, O. N. Tkacheva, A. S. Lishuta | ||
"... with rosuvastatin. Target level of total cholesterol (<4 mmol/L) was achieved in 2.04-7.38% of the patients ..." | ||
Vol 13, No 6 (2017) | SUBFRACTION DISTRIBUTION OF APO B-CONTAINING LIPOPROTEINS DEPENDING ON THE ACHIEVEMENT OF THE TARGET LEVEL OF LOW DENSITY LIPOPROTEINS UNDER STATINS THERAPY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS | Abstract similar documents |
I. N. Ozerova, V. A. Metelskaya, N. E. Gavrilova | ||
"... before admission: atorvastatin (10-40 mg/day), simvastatin (20-40 mg/day), rosuvastatin (10-40 mg/day ..." | ||
Vol 8, No 6 (2012) | MODERN VIEWS ON THE VARIABILITY OF BLOOD PRESSURE | Abstract similar documents |
V. M. Gorbunov | ||
"... in patients of amlodipine/perindopril treatment group was significantly lower than this in patients ..." | ||
Vol 5, No 4 (2009) | TOLERABILITY OF VARIOUS ANTIHYPERTENSIVE COMBINATIONS | Abstract similar documents |
S. V. Malchikova, E. I. Tarlovskaya | ||
"... /perindopril; group B - indapamide retard/amlodipine; group C – amlodipine/lisinopril; group D – amlodipine ..." | ||
Vol 14, No 2 (2018) | THE ANALYSIS OF DIFFERENCES IN DOCTORS PREFERENCES IN THE PRESCRIPTIONS OF ANTIHYPERTENSIVE DRUGS IN FOUR REGIONS OF THE FAR EASTERN FEDERAL DISTRICT | Abstract similar documents |
M. S. Soboleva, Е. E. Loskutova | ||
"... .6% to 27%), lisinopril (from 4.4% to 23.9%) and perindopril (from 0.9% to 7.8%); among calcium channel ..." | ||
Vol 1, No 3 (2005) | COMPARATIVE ASSESSMENT OF EFFECT OF COMBINED DRUGS OF ACE INHIBITOR AND DIURETIC (“NOLIPREL FORTE” AND “CAPOZIDE”) ON CARDIOVASCULAR REMODELING IN HYPERTENSIVE PATIENTS | Abstract similar documents |
T. D. Kaplanov, V. V. Ivanenko, N. V. Ryasancevа, A. V. Legkiy, L. P. Anisimova, Yu. M. Lopatin | ||
"... of combined drug of ACE inhibitors and diuretic. 25 patients took NF (perindopril 4 mg and indapamide 1,25 mg ..." | ||
Vol 10, No 5 (2014) | CHOICE OF THE INITIAL TREATMENT FOR MILD TO MODERATE ARTERIAL HYPERTENSION IN MOSCOW PRIMARY PRACTICE | Abstract similar documents |
S. V. Gatsura, O. A. Gatsura, A. N. Golosova | ||
"... was Noliprel, perindopril/indapamide fixed combination, – 14.0% and 13.7% of respondents in 2011-12 and 2013-14 ..." | ||
Vol 16, No 4 (2020) | Studying the Possibility of Optimizing the Statin Therapy Algorithm in Outpatient Practice | Abstract similar documents |
D. V. Nebieridze, N. M. Akhmedzhanov, S. A. Davitashvili, A. S. Lishuta, A. S. Safaryan | ||
"... atorvastatin (10-80 mg/day) or rosuvastatin (10-40 mg/day). Group 1 patients had visits to the doctor after 1 ..." | ||
Vol 17, No 1 (2021) | Optimization of the Statin Therapy Algorithm in Outpatient Practice: Adherence and Economic Benefits | Abstract similar documents |
S. A. Davitashvili, D. V. Nebieridze, N. M. Akhmedzhanov, A. S. Lishuta, A. S. Safaryan | ||
"... atorvastatin (10-80 mg/day) or rosuvastatin (10- 40 mg/day). Group 1 patients had visits to the doctor after 1 ..." | ||
Vol 18, No 1 (2022) | Challenges of Statin Therapy in Clinical Practice (According to Outpatient Register «PROFILE» Data) | Abstract PDF (Eng) similar documents |
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, A. V. Zagrebelnyy, S. N. Tolpygina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. S. Nekoshnova, I. V. Budaeva, S. V. Blagodatskikh, B. B. Aslanova | ||
"... .2-5.3 (p<0.001). Doctors preferred atorvastatin in prescriptions (n=456, 55.4%), rosuvastatin (n=244 ..." | ||
Vol 14, No 2 (2018) | FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova | ||
"... the number of recommendations of enalapril increased up to 50.8%, perindopril – up to 24.1%. Analysis ..." | ||
Vol 14, No 1 (2018) | IDENTIFICATION OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE RUSSIAN POPULATION USING THE EXAMPLE OF MOSCOW CITY AND MOSCOW REGION | Abstract similar documents |
I. V. Sergienko, A. A. Ansheles | ||
"... with severe HCh was 18.3%. Monotherapy with atorvastatin (34.2%) or rosuvastatin (31.8%), combined therapy ..." | ||
Vol 8, No 3 (2012) | EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES | Abstract similar documents |
O. A. Koshel'skaya, O. A. Zhuravleva | ||
"... therapy with valsartan (n=20), 80–160 mg/day , or perindopril (n=21), 5–10 mg/day , in combination ..." | ||
Vol 8, No 5 (2012) | EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN ACHIEVEMENT OF TARGET BLOOD PRESSURE IN DIABETIC PATIENTS | Abstract similar documents |
O. A. Koshel'skaya, O. A. Zhuravleva, R. S. Karpov | ||
"... to moderate DM type 2 were included into the study. The patients were treated with perindopril (5–10 mg/day ..." | ||
Vol 14, No 5 (2018) | The Potential of the Volumetric Sphygmography for the Diagnosis of Impaired Arterial Stiffness in Patients with Uncomplicated Arterial Hypertension and Its Possibilities for Evaluation of the Antihypertensive Therapy Effectiveness | Abstract similar documents |
E. V. Borisova, A. I. Kochetkov, O. D. Ostroumova | ||
"... with SPC (perindopril arginine/indapamide or valsartan/amlodipine) achieved the target BP level (<140/90 mm ..." | ||
Vol 15, No 2 (2019) | Assessment of the Adequacy of Drug Choice in Patients with Acute Myocardial Infarction According to the PROFILE-IM Registry | Abstract similar documents |
S. Yu. Martsevich, N. P. Kutishenko, E. P. Kalaydzhyan, D. P. Sichinava, V. A. Evdakov | ||
"... . When choosing ACEI, priority was given to perindopril, with which no one randomized clinical trial ..." | ||
Vol 17, No 2 (2021) | The Importance of Antihypertensive and Lipid-Lowering Therapy in the Treatment of Patients with a New Coronavirus Infection COVID-19 | Abstract similar documents |
V. I. Podzolkov, A. I. Tarzimanova | ||
"... and rosuvastatin is an effective drug that allows achieving not only adequate hypotensive and lipid-lowering ..." | ||
Vol 9, No 4 (2013) | REAL PRACTICE OF STATINS USE AND ITS DEPENDENCE ON FOLLOW-UP IN THE SPECIALIZED MEDICAL CENTRE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (ACCORDING TO THE PROFILE REGISTER) | Abstract similar documents |
S. Yu. Martsevich, O. V. Gaisenok, S. G. Tripkosh, Yu. V. Lukina, A. V. Zagrebel’nyy | ||
"... , назначением оригинального препарата, а также с применением розувастатина. Показатели безопасности терапии ..." | ||
1 - 74 of 74 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)